Search

Background: Carcinoma pancreas is increasingly being identified by conventional imaging techniques such as ultrasonography (USG), computed tomography (CT) scans, and magnetic resonance imaging (MRI). Imaging also allows for the evaluation of resectability. MRI and CT scans are not generally available in our nation, and most pancreatic carcinomas are too advanced for curative surgical resection when discovered. These are unresectable pancreatic carcinomas (UCP). Objective: In this study our main goal is to evaluate the efficacy of imaging in diagnosing carcinoma pancreas and to assess respectability after comparing them with per-operative findings. Method: This prospective study was done at tertiary medical hospital from January 2021 to January 2022. Where Hospital records of all 150 pancreatic carcinoma patients admitted during the period were retrospectively analyzed. Pre-operatively labeled unresectable carcinoma pancreas patients that underwent laparotomy with histopathological proof during this period were included for the study. Total 150 patients were labeled as ‘unresectable carcinoma. All patients were evaluated by USG and CT scan. MRI was done where USG /CT scan had failed to give any clue about the diagnosis in clinically suspected 8 carcinoma pancreas patients. Results: During the study, majority were belonging to >60 years age group, 65%. USG was able to diagnose 85% with pancreatic cancer followed by CT and MRI scan was able to diagnose 90% and 100% with pancreatic cancer. According to per-operative findings most of the lesions were found at the head of the pancreas, 75%, followed by 16% cases were in body and 9% cases were tail. However, the situation is quite different in USG and CT findings. Where in USG 80% cases were head and In CT it was 70%. Moreover, in MRI it was 78%. According to pre-operative findings ascites was seen in 25% cases, however according to USG it was 18% cases, in CT it was 23%, and in MRI it was 15% cases. USG was able to ......